Trial · NCT07906366
Building Resilience Through Anxiety Virtual Education in PICU Survivors
NCT07906366, Not applicable, Not yet recruiting, University of Rochester
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Building Resilience Through Anxiety Virtual Education in PICU Survivors. Trials, record NCT07906366. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07906366
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Building Resilience Through Anxiety Virtual Education in PICU Survivors
- NCT number
- NCT07906366
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 70 participants, estimated
- Lead sponsor
- University of Rochester
- Conditions
- Critical Illness Recovery, Mental Health
- Interventions
- Digital Cognitive Behavioral Therapy
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Screen for Child Anxiety and Related Disorders (SCARED) | Baseline and 12 weeks | Subjects in both arms will receive Screen for Child Anxiety and Related Disorders (SCARED) instrument upon enrollment (baseline) and at study completion (12 weeks). This instrument is scored from 0 to 82 (2 points per question) and provides a measure of anxiety, avoidance, and panic disorders. Higher scores indicate greater anxiety and related disorders. It was developed by Boris Birmaher, MD, Suneeta Khetarpal, MD, Marlane Cully, MEd, David Brent, MD, and Sandra McKenzie, PhD, Western Psychiatric Institute and Clinic, University of Pittsburgh. |
| Secondary | System Usage | 12 Weeks | Usage data of the dCBT product will be provided for subjects in the intervention arm. We will receive information about the number of logins and the active time spent in the system. |
| Secondary | System Usability Scales | 12 Weeks | Subjects in the intervention arm will receive the System Usability Scales instrument at study completion. This scale measures the usability of the Camp Cope-a-lot system and was adapted from the SUS developed by John Brooke in 1986. It is scored from 0 to 100, with higher scores meaning greater usability. |
| Secondary | Child and Adolescent Trauma Screen (CATS) | Baseline | Subjects in both arms will receive the Child and Adolescent Trauma Screen (CATS) at baseline. This instrument asks about stressful or scary events that happened to the subject. It is scored from 0 to 15, with higher scores indicating more trauma history. It was developed by Prof. Lutz Goldbeck (Ph.D.) \& Prof. Lucy Berliner (Ph.D.). |
| Secondary | Barriers to Treatment Participation Scale (BTPS) | Baseline | Subjects in both arms will receive the Barriers to Treatment Participation Scale (BTPS) at Baseline. It asks questions about specific barriers to seeking psychological help, counseling, or advice for the subject. It is scored from 1 to 38 with higher scores indicating greater barriers to treatment participation. |
| Secondary | Digital Competence Scale | Baseline | Subjects in both arms will receive the Digital Competence Scale at Baseline. It is a short self-assessment instrument for measuring digital competencies. It is scored from 0 to 12 with higher scores indicating greater digital competence. It was developed by Schwarz (2024). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07906366
GET https://conductscience.org/api/trials/v1/NCT07906366/registered